Skip to main content
LymeCare Alliance Logo
Send Your Case

A Case of Missed Neuroborreliosis Diagnosis in Bulgaria: The Devastating Consequences of Diagnostic Failures

Share on LinkedIn Facebook

Published on:

Introduction

A.R., a male patient from Bulgaria, has experienced a tragic progression of neurological symptoms following a tick bite in 2019. Despite his early pursuit of medical attention, his condition worsened due to repeated diagnostic failures and the dismissal of his symptoms by multiple medical professionals. Over the past several years, A.R. has spent approximately BGN 40,000 (€20,000) on various tests and medical consultations, only to receive inadequate care. Initially, he was met with mockery from his general practitioner, who dismissed his symptoms inappropriately. A neurologist later ordered testing for Lyme disease using the ELISA method, which came back negative, further delaying appropriate treatment.

A.R.’s condition has deteriorated to the point where he is now completely bedridden and reliant on his family for all basic care. His pursuit of a definitive diagnosis and treatment has been marred by the shortcomings of the Bulgarian healthcare system, reliance on outdated diagnostic tests, and a lack of transparency regarding the testing methods used. Despite multiple consultations with leading Bulgarian doctors, including a prominent professor at Sofiamed Hospital who suspected neuroborreliosis, A.R. was repeatedly denied treatment due to negative results from inappropriate diagnostic tests. Tests abroad eventually confirmed an infection with Ehrlichia and positive Lyme disease results, but by then, his condition had deteriorated to permanent disability.

Conclusion

A.R.'s case illustrates the dire consequences of systemic failures in diagnosing Lyme disease and its coinfections in Bulgaria. His progression from a treatable tick-borne infection to permanent disability demonstrates how inadequate testing protocols, reliance on outdated diagnostic tools, and the dismissal of patient symptoms can lead to catastrophic health outcomes. A.R.’s case underscores the urgent need for modernization of Lyme disease testing, more thorough investigation of tick-borne infections, and better training for healthcare professionals in recognizing and treating these conditions.

Medical History

  • Initial Symptoms (2019): A.R. was bitten by a tick in 2019 and began experiencing neurological symptoms, including fatigue, dizziness, and general weakness. His general practitioner dismissed his symptoms inappropriately, joking that his symptoms were due to a lack of alcohol consumption.
  • Neurological Decline: Over the next several years, A.R.'s symptoms worsened significantly, leading to muscle weakness, mobility issues, and the gradual loss of independence. He sought medical advice from a neurologist who ordered an ELISA test for Lyme disease, but the test result was negative.
  • Costly Medical Investigations: A.R. financed numerous medical examinations out of pocket, spending approximately BGN 40,000 (€20,000) on tests, imaging studies, and consultations with specialists, including prominent physicians in Bulgaria. Despite his financial investment and effort, A.R. did not receive an adequate diagnosis or effective treatment.

Symptoms

  • Neurological Symptoms: Progressive neurological deterioration, including mixed motor and sensory symptoms, severe muscle weakness, loss of coordination, and mobility.
  • Dependency on Others: As A.R.'s condition worsened, he became entirely dependent on family members for basic care, such as feeding, bathing, and mobility assistance.
  • Deteriorating Mental Health: A.R.’s mental health declined significantly as he experienced frustration, hopelessness, and a sense of abandonment by the medical community. These feelings were compounded by the repeated misdiagnoses and dismissive attitudes of several healthcare providers.

Diagnostic Tests

  1. ELISA Test (Bulgaria, 2019): Initial testing for Lyme disease via ELISA was negative. ELISA is known for its limitations in detecting chronic or late-stage infections, particularly for European strains of Borrelia. This led to the initial dismissal of Lyme disease as a potential diagnosis.
  2. Tests at NCIPD (Bulgaria): Additional tests at the National Center for Infectious and Parasitic Diseases (NCIPD) also returned negative results. However, these tests were designed to detect the American strain of Borrelia burgdorferi, which is rare in Europe. This misalignment between the test and the prevalent strains in the region led to false-negative results.
  3. LTT Test (Abroad): A.L. sent blood samples abroad for further testing, including the LTT (Lymphocyte Transformation Test) method. This test showed positive results for Borrelia infection, as well as Ehrlichia, a co-infection of Borrelia not commonly recognized in Bulgaria.
  4. Western Blot (Private Lab, Bulgaria): A Western Blot test conducted in a private laboratory in Sofia returned positive for Borrelia, specifically European strains of the bacterium. This confirmed A.R.'s Lyme disease diagnosis, but the medical community in Bulgaria remained dismissive of the results.

Diagnosis and Treatment

Despite strong clinical evidence pointing toward neuroborreliosis, A.R.’s diagnosis and treatment were repeatedly delayed due to negative ELISA tests and the lack of recognition of European Borrelia strains in Bulgaria. After consulting with a prominent professor at Sofiamed Hospital, neuroborreliosis was suspected, but the professor declined to pursue treatment after the results from NCIPD were negative. A.R. was also promised inclusion in a "new special program" for Lyme disease diagnostics at NCIPD, but this never materialized, leaving him without appropriate care.

It was only after sending blood samples abroad that A.R. was diagnosed with Ehrlichia, a co-infection of Borrelia. This diagnosis came far too late to prevent the severe neurological decline he had already experienced. While antibiotic therapy was initiated based on the foreign test results, it provided only temporary relief and was insufficient to reverse his advanced neurological symptoms. His ongoing struggle to receive adequate care in Bulgaria has left him bedridden and disabled.

Outcomes

  • Delayed Diagnosis: A.R.’s condition deteriorated significantly due to years of misdiagnosis and delayed treatment. His neurological symptoms worsened, and he became unable to move or care for himself, relying entirely on family members for basic daily needs.
  • Refusal of Treatment: Bulgarian hospitals and medical professionals continued to refuse treatment even after positive tests from abroad confirmed Lyme disease and Ehrlichia. The reliance on outdated testing methods and a lack of recognition of European Borrelia strains contributed to this failure.
  • Financial Burden: A.R. spent approximately BGN 40,000 (€20,000) on medical tests and consultations, further compounding the emotional and physical toll of his undiagnosed condition.

Differential Diagnosis

  • Neuroborreliosis: Given A.R.'s neurological symptoms and positive Lyme disease tests from abroad, neuroborreliosis remains the most likely diagnosis. Neuroborreliosis, a manifestation of Lyme disease, can lead to severe neurological symptoms, including paralysis, muscle weakness, and cognitive decline.
  • Ehrlichia Coinfection: The detection of Ehrlichia further complicates A.R.'s condition. Ehrlichia is a tick-borne bacterial infection often found as a co-infection with Lyme disease. It can exacerbate Lyme disease symptoms and complicate treatment.
  • Amyotrophic Lateral Sclerosis (ALS): At one point, A.R. was suspected to have ALS, a fatal neurological disease. However, this diagnosis was never confirmed, and his symptoms are more consistent with neuroborreliosis and co-infections than ALS.
  • Psychiatric Disorder: Some physicians speculated that A.R.'s condition was psychiatric in nature. This misdiagnosis further delayed appropriate treatment and added to the patient’s frustration.

Future Recommendations

  • Comprehensive Lyme Disease Treatment: A.R. requires a comprehensive treatment plan to address both Lyme disease and Ehrlichia. This should include long-term antibiotic therapy, immune system support, and rehabilitation services to address his neurological damage.
  • Modernization of Diagnostic Protocols in Bulgaria: The reliance on outdated and inappropriate diagnostic tests, such as the ELISA test designed for the American strain of Borrelia, must be addressed. The inclusion of more sensitive tests, such as the Western Blot, and tests for European strains of Borrelia is critical to improving diagnostic accuracy in Bulgaria.
  • Better Patient Advocacy and Transparency: A.R.'s case highlights the need for greater transparency in medical testing and better advocacy for patients with complex conditions. Bulgarian citizens should have access to information about the tests being conducted and the strains of bacteria being tested.
  • Follow-up and Continued Monitoring: A.R. needs continued monitoring for both Lyme disease and co-infections, such as Ehrlichia, with ongoing evaluation by a Lyme-literate specialist. Rehabilitation and supportive care should be provided to manage his long-term disabilities.
  • Psychological Support: Given the profound emotional toll of A.R.'s long-term misdiagnosis and physical deterioration, psychological support for both the patient and his family is crucial.

Discussion

Lyme disease, particularly its neurological form known as neuroborreliosis, can be devastating if not diagnosed and treated early. A.R.'s case illustrates how delays in diagnosis, mismanagement, and the use of outdated testing methods can lead to severe, life-altering consequences. The ELISA test, which is commonly used as a first-line diagnostic tool, is known for its poor sensitivity in late-stage Lyme disease, particularly for European strains of Borrelia. A.R.'s reliance on this test, coupled with the dismissive attitude of many healthcare providers, resulted in years of suffering and eventual disability.

The issue of misdiagnosis is compounded by the fact that many healthcare providers in Bulgaria do not recognize the full spectrum of tick-borne infections, such as Ehrlichia, and fail to adopt more advanced diagnostic tools. A.R.'s condition continued to worsen as medical professionals dismissed his symptoms, attributing them to psychiatric or psychosomatic causes. It was only after testing abroad that the correct diagnoses of Lyme disease and Ehrlichia were made, but by that time, the damage was irreversible.

The reliance on outdated tests for the American strain of Borrelia, which is rare in Europe, reflects a broader issue of underdiagnosis in Bulgaria and many other parts of Europe. With the rise in tick-borne infections across the continent, there is a pressing need for healthcare systems to modernize their approach to Lyme disease diagnosis and treatment.

Broader Implications

A.R.'s case is a sobering reminder of the consequences of medical system failures. His years of misdiagnosis and mistreatment have left him permanently disabled, a fate that could have been avoided with earlier recognition of his condition. The case underscores the importance of updating diagnostic protocols for Lyme disease and its coinfections, ensuring that European strains of Borrelia are properly recognized in testing procedures.

There is also a need for better training and education for healthcare providers, particularly in countries like Bulgaria, where tick-borne infections are becoming increasingly prevalent. The medical community must move away from dismissing patients’ symptoms and focus on thorough investigation and proper diagnostic testing. A.R.’s journey through the healthcare system serves as a cautionary tale, urging for systemic reform to prevent future patients from suffering the same fate.

Analysis of A.R.'s Case: Systemic Failures in the Diagnosis and Treatment of Tick-Borne Infections in Bulgaria

A.R.'s case is a tragic example of how systemic failures in the diagnosis and management of tick-borne infections, particularly Lyme disease and its coinfections, can lead to devastating outcomes. Despite early medical attention following a tick bite in 2019, A.R.’s condition rapidly declined due to repeated diagnostic errors, reliance on outdated tests, and the dismissal of his symptoms by numerous medical professionals. His journey highlights the urgent need for modernization of diagnostic protocols, better patient advocacy, and more comprehensive training for healthcare providers in Bulgaria.

Diagnostic Failures and the Consequences of Outdated Testing Methods

The cornerstone of A.R.’s misdiagnosis lies in the inappropriate reliance on the ELISA test, a first-line serological test with significant limitations in detecting late-stage or chronic Lyme disease, particularly in European settings. The ELISA test, which detects antibodies to Borrelia, is known for its poor sensitivity, especially in cases where the patient’s immune response has waned, as is often the case in long-standing infections. In A.R.’s case, the negative ELISA result delayed appropriate treatment and allowed his neurological symptoms to progress unchecked.

Moreover, the ELISA test used in A.R.'s case was designed to detect the American strain of Borrelia burgdorferi, which is rare in Europe. The failure to recognize and use tests that detect European strains of Borrelia (such as Borrelia garinii and Borrelia afzelii) further contributed to A.R.’s misdiagnosis. Despite clear clinical signs suggestive of neuroborreliosis, including severe neurological decline and muscle weakness, his doctors repeatedly dismissed Lyme disease as a possible diagnosis, relying heavily on this flawed test.

A.R.’s later decision to pursue more advanced diagnostic testing abroad, including the Lymphocyte Transformation Test (LTT) and Western Blot, ultimately confirmed both Lyme disease and Ehrlichia infection. The LTT, which measures cellular immune responses to tick-borne pathogens, provided a more accurate assessment of A.R.'s condition, while the Western Blot confirmed the presence of European strains of Borrelia. Unfortunately, by the time these results were obtained, the delay in diagnosis had resulted in irreversible neurological damage.

Systemic Healthcare Failures: Dismissal of Symptoms and Delayed Treatment

Beyond the diagnostic failures, A.R.'s case is a stark example of the consequences of medical dismissal and the lack of transparency in patient care. His early experiences with healthcare providers—most notably his general practitioner who mockingly dismissed his symptoms—reflect a broader issue of medical neglect. Tick-borne infections, particularly Lyme disease, are often misunderstood or underestimated in many healthcare settings, leading to patient frustration and prolonged suffering. A.R.’s progression from a treatable infection to permanent disability was exacerbated by the dismissive attitudes of multiple healthcare providers, who failed to consider his symptoms seriously even after he consulted a prominent neurologist.

The refusal of treatment, even after positive diagnostic results were obtained abroad, further illustrates a troubling disconnect between the use of modern diagnostic tools and their recognition in clinical practice. Despite confirmed infections with both Borrelia and Ehrlichia, Bulgarian healthcare providers remained hesitant to provide adequate treatment, largely due to the reliance on outdated tests and protocols. This reflects a systemic issue in Bulgaria and other parts of Europe, where tick-borne infections may not be fully recognized or treated due to entrenched diagnostic approaches.

The Financial and Emotional Toll on Patients

A.R.’s financial investment in his health journey is another significant aspect of this case. Over the years, he spent approximately BGN 40,000 (€20,000) on medical tests, consultations, and treatments, yet these expenses yielded little benefit. His story is a reminder that, in many cases, patients are left bearing the financial burden of a system that fails to meet their needs. The substantial costs of seeking care abroad and undergoing private testing are not sustainable for most patients, further highlighting the need for reform in local healthcare systems to ensure that accurate diagnostic tools and treatments are accessible to all.

Beyond the financial cost, the emotional toll on A.R. is immeasurable. The repeated dismissal of his symptoms, the failure to find a diagnosis, and the eventual progression to total dependency on his family have likely compounded his feelings of despair and hopelessness. His declining mental health is a direct result of the prolonged suffering and neglect he experienced, a common phenomenon among patients with chronic Lyme disease and other poorly understood infections.

The Need for Modernized Diagnostic and Treatment Protocols

A.R.’s case is a stark example of the need for modernization in diagnostic and treatment protocols for Lyme disease and its coinfections in Bulgaria. Reliance on outdated serological tests like ELISA, particularly those designed for American strains of Borrelia, is a critical flaw in the current healthcare approach. The inclusion of more sensitive tests—such as the Western Blot, LTT, and PCR—into routine diagnostic procedures is essential for improving accuracy and ensuring that European strains of tick-borne pathogens are recognized.

In addition to updated diagnostic protocols, there is a need for greater recognition of coinfections like Ehrlichia, which further complicate the clinical picture in tick-borne infections. A.R.’s eventual diagnosis of Ehrlichia came too late to reverse his neurological decline, but early detection could have significantly altered his treatment course and outcome.

The Importance of Training and Education for Healthcare Providers

A.R.’s tragic outcome also underscores the need for better education and training for healthcare providers in Bulgaria. Tick-borne infections are becoming increasingly prevalent in Europe, yet many healthcare professionals remain unaware of the full spectrum of symptoms, coinfections, and diagnostic challenges associated with these diseases. Improved training on the nuances of tick-borne infections—particularly the differences between European and American strains of Borrelia—would equip doctors to make more informed decisions and prevent future cases from escalating to the point of permanent disability.

Broader Implications for Healthcare Policy

A.R.’s case has broader implications for healthcare policy in Bulgaria and similar regions where diagnostic protocols are outdated, and tick-borne infections are underrecognized. His experience highlights the need for a comprehensive overhaul of the way Lyme disease and its coinfections are approached in clinical practice. Healthcare systems must prioritize the adoption of modern diagnostic tools and provide greater transparency about the limitations of existing tests.

Furthermore, patients like A.R. need better access to patient advocacy and support services to navigate complex medical systems. Medical professionals should be trained to take patient symptoms seriously and avoid dismissing their concerns, particularly in cases where diagnostic results may be inconclusive. A more patient-centered approach would prevent the kind of medical negligence that A.R. faced and ensure that patients are not left to suffer without a clear diagnosis or treatment plan.

Conclusion: A Call for Reform in Tick-Borne Disease Management

A.R.’s case is a devastating example of the consequences of systemic healthcare failures in diagnosing and treating tick-borne infections. His journey from a treatable infection to permanent disability underscores the urgent need for reform in the diagnostic and treatment protocols for Lyme disease and its coinfections in Bulgaria. The reliance on outdated testing methods, the dismissal of patient symptoms, and the lack of transparency in medical care have all contributed to A.R.’s tragic outcome.

To prevent similar cases in the future, healthcare systems must modernize their approach to tick-borne infections by adopting more sensitive and specific diagnostic tools, improving training for healthcare providers, and ensuring that patients receive timely and effective treatment. A.R.’s story should serve as a catalyst for change, highlighting the critical importance of early diagnosis, comprehensive treatment, and patient advocacy in managing complex infections like Lyme disease and Ehrlichia. Without these changes, more patients will continue to suffer unnecessarily, caught in the gaps of a healthcare system that fails to recognize and treat these debilitating conditions.

Latest Case Studies

Latest publications